Monday, March 2, 2009

Valeant Slashes Research as Solution to Drug Pipeline Woes

The company takes an acquisition strategy a step beyond what most major drug companies are doing.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)